Submitted:
05 February 2025
Posted:
05 February 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Overall Approach
2.2. Study Design and Population
2.3. Spatial Registered Vectorial 3D Image Assembly: Magnetic Resonance Imaging
2.4. Spatial Registered Vectorial 3D Image Assembly: Image Processing, Pre-Analysis
2.5. Overall Quantitative Metrics Description: SCR, Z-Score
2.6. SCR: Filtering Noise
2.7. Regularization and Shrinkage
2.8. Logistic Regression
2.9. Adaptive Cosine Estimator (ACE) Algorithm
2.10. Tumor Volume Measurements, Supervised Target Detection
2.11. Labeling and Blob Generation
2.12. Eccentricity Calculation
2.13. Machine Learning Application: Z-SSMNet
2.14. Univariate and Multivariate Fitting
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| SSA | Spectral/Statistics Approach |
| SCR | Signal to Clutter Ratio |
| ACE | Adaptive Cosine Estimator |
| AUROC | Area Under the Curve |
| AP | Average Precision |
| BP-MRI | Bi-parametric MRI |
| CsPCa | Clinically Significant Prostate Cancer |
| ROC | Receiver Operator Characteristic |
| Mod Reg | Modified Regularization |
| Reg | Regularization |
| PC | Principal Component |
| DL | Deep Learning |
| AI | Artificial Intelligence |
| ISUP | International Society Urological Pathology |
| PI-RADS | Prostate Imaging Reporting and Data System |
| PI-CAI | Prostate Imaging Artificial Intelligence |
| Z-SSMNet | Zonal-Aware Self-Supervised Mesh Network |
References
- Papachristodoulou A, Abate-Shen C. Precision intervention for prostate cancer: Re-evaluating who is at risk. Cancer Lett. 2022 Jul 10;538:215709. [CrossRef] [PubMed]
- Parker, C.; Castro, E.; Fizazi, K.; Heidenreich, A.; Ost, P.; Procopio, G.; Tombal, B.; Gillessen, S. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2020, 31, 1119–1134. [Google Scholar] [CrossRef] [PubMed]
- Wang T, Lewis B, Ruscetti M, Mittal K, Wang MJ, Sokoloff M, Ding L, Bishop-Jodoin M, FitzGerald TJ. Prostate Cancer: Advances in Radiation Oncology, Molecular Biology, and Future Treatment Strategies. In: Barber N, Ali A, editors. Urologic Cancers [Internet]. Brisbane (AU): Exon Publications; 2022 Sep 12. Chapter 13. [PubMed]
- Williams IS, McVey A, Perera S, O'Brien JS, Kostos L, Chen K, Siva S, Azad AA, Murphy DG, Kasivisvanathan V, Lawrentschuk N, Frydenberg M. Modern paradigms for prostate cancer detection and management. Med J Aust. 2022 Oct 17;217(8):424-433. [CrossRef] [PubMed]
- Ziglioli F, Granelli G, Cavalieri D, Bocchialini T, Maestroni U. What chance do we have to decrease prostate cancer overdiagnosis and overtreatment? A narrative review. Acta Biomed. 2019 Dec 23;90(4):423-426. [CrossRef] [PubMed]
- Zuur LG, de Barros HA, van der Mijn KJC, Vis AN, Bergman AM, Pos FJ, van Moorselaar JA, van der Poel HG, Vogel WV, van Leeuwen PJ. Treating Primary Node-Positive Prostate Cancer: A Scoping Review of Available Treatment Options. Cancers (Basel). 2023 May 29;15(11):2962. [CrossRef] [PubMed]
- Zattoni F, Rajwa P, Miszczyk M, Fazekas T, Carletti F, Carrozza S, Sattin F, Reitano G, Botti S, Matsukawa A, Dal Moro F, Jeffrey Karnes R, Briganti A, Novara G, Shariat SF, Ploussard G, Gandaglia G. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy: A Systematic Review and Meta-analysis of Prospective Studies. Eur Urol Oncol. 2024 Dec;7(6):1303-1312. [CrossRef] [PubMed]
- Zhou M, Epstein JI. The reporting of prostate cancer on needle biopsy: prognostic and therapeutic implications and the utility of diagnostic markers. Pathology. 2003 Dec;35(6):472-9. [CrossRef] [PubMed]
- Bloemberg J, de Vries M, van Riel LAMJG, de Reijke TM, Sakes A, Breedveld P, van den Dobbelsteen JJ. Therapeutic prostate cancer interventions: a systematic review on pubic arch interference and needle positioning errors. Expert Rev Med Devices. 2024 Jul;21(7):625-641. [CrossRef] [PubMed]
- Zhu M, Liang Z, Feng T, Mai Z, Jin S, Wu L, Zhou H, Chen Y, Yan W. Up-to-Date Imaging and Diagnostic Techniques for Prostate Cancer: A Literature Review. Diagnostics (Basel). 2023 Jul 5;13(13):2283. [CrossRef] [PubMed]
- Fernandes MC, Yildirim O, Woo S, Vargas HA, Hricak H. The role of MRI in prostate cancer: current and future directions. MAGMA. 2022 Aug;35(4):503-521. [CrossRef] [PubMed]
- Tricard T, Garnon J, Cazzato RL, Al Hashimi I, Gangi A, Lang H. "Prostate management" under MRI-guidance: 7 years of improvements. Transl Cancer Res. 2020 Apr;9(4):2280-2286. [CrossRef] [PubMed]
- Triquell M, Campistol M, Celma A, Regis L, Cuadras M, Planas J, Trilla E, Morote J. Magnetic Resonance Imaging-Based Predictive Models for Clinically Significant Prostate Cancer: A Systematic Review. Cancers (Basel). 2022 Sep 29;14(19):4747. [CrossRef] [PubMed]
- Würnschimmel C, Chandrasekar T, Hahn L, Esen T, Shariat SF, Tilki D. MRI as a screening tool for prostate cancer: current evidence and future challenges. World J Urol. 2023 Apr;41(4):921-928. [CrossRef] [PubMed]
- Kamsut S, Reid K, Tan N. Roundtable: arguments in support of using multi-parametric prostate MRI protocol. Abdom Radiol (NY). 2020 Dec;45(12):3990-3996. [CrossRef] [PubMed]
- Stabile, A.; Giganti, F.; Rosenkrantz, A.B.; Taneja, S.S.; Villeirs, G.; Gill, I.S.; Allen, C.; Emberton, M.; Moore, C.M.; Kasivisvanathan, V. Multiparametric MRI for prostate cancer diagnosis: Current status and future directions. Nat. Rev. Urol. 2020, 17, 41–61. [Google Scholar] [CrossRef] [PubMed]
- Ursprung S, Herrmann J, Nikolaou K, Harland N, Bedke J, Seith F, Zinsser D. Die multiparametrische MRT der Prostata: Anforderungen und Grundlagen der Befundung [Multiparametric MRI of the prostate: requirements and principles regarding diagnostic reporting]. Urologie. 2023 May;62(5):449-458. German. [CrossRef] [PubMed]
- Zhao Y, Simpson BS, Morka N, Freeman A, Kirkham A, Kelly D, Whitaker HC, Emberton M, Norris JM. Comparison of Multiparametric Magnetic Resonance Imaging with Prostate-Specific Membrane Antigen Positron-Emission Tomography Imaging in Primary Prostate Cancer Diagnosis: A Systematic Review and Meta-Analysis. Cancers (Basel). 2022 Jul 19;14(14):3497. [CrossRef] [PubMed]
- Ziglioli F, Maestroni U, Manna C, Negrini G, Granelli G, Greco V, Pagnini F, De Filippo M. Multiparametric MRI in the management of prostate cancer: an update-a narrative review. Gland Surg. 2020 Dec;9(6):2321-2330. [CrossRef] [PubMed]
- Scott R, Misser SK, Cioni D, Neri E. PI-RADS v2.1: What has changed and how to report. SA J Radiol. 2021 Jun 1;25(1):2062. [CrossRef] [PubMed]
- Spilseth B, Margolis DJA, Gupta RT, Chang SD. Interpretation of Prostate Magnetic Resonance Imaging Using Prostate Imaging and Data Reporting System Version 2.1: A Primer. Radiol Clin North Am. 2024 Jan;62(1):17-36. [CrossRef] [PubMed]
- Annamalai A, Fustok JN, Beltran-Perez J, Rashad AT, Krane LS, Triche BL. Interobserver Agreement and Accuracy in Interpreting mpMRI of the Prostate: a Systematic Review. Curr Urol Rep. 2022 Jan;23(1):1-10. [CrossRef] [PubMed]
- Taya M, Behr SC, Westphalen AC. Perspectives on technology: Prostate Imaging-Reporting and Data System (PI-RADS) interobserver variability. BJU Int. 2024 Oct;134(4):510-518. [CrossRef] [PubMed]
- Padhani, A.R.; Schoots, I.; Villeirs, G. Contrast Medium or No Contrast Medium for Prostate Cancer Diagnosis. That Is the Question. J. Magn. Reson. Imaging. 2021, 53, 13–22. [Google Scholar] [CrossRef] [PubMed]
- Palumbo P, Manetta R, Izzo A, Bruno F, Arrigoni F, De Filippo M, Splendiani A, Di Cesare E, Masciocchi C, Barile A. Biparametric (bp) and multiparametric (mp) magnetic resonance imaging (MRI) approach to prostate cancer disease: a narrative review of current debate on dynamic contrast enhancement. Gland Surg. 2020 Dec;9(6):2235-2247. [CrossRef] [PubMed]
- Pecoraro M, Messina E, Bicchetti M, Carnicelli G, Del Monte M, Iorio B, La Torre G, Catalano C, Panebianco V. The future direction of imaging in prostate cancer: MRI with or without contrast injection. Andrology. 2021 Sep;9(5):1429-1443. [CrossRef] [PubMed]
- Scialpi M, D'Andrea A, Martorana E, Malaspina CM, Aisa MC, Napoletano M, Orlandi E, Rondoni V, Scialpi P, Pacchiarini D, Palladino D, Dragone M, Di Renzo G, Simeone A, Bianchi G, Brunese L. Biparametric MRI of the prostate. Turk J Urol. 2017 Dec;43(4):401-409. [CrossRef] [PubMed]
- Scialpi M, Martorana E, Scialpi P, D'Andrea A, Torre R, Di Blasi A, Signore S. Round table: arguments in supporting abbreviated or biparametric MRI of the prostate protocol. Abdom Radiol (NY). 2020 Dec;45(12):3974-3981. [CrossRef] [PubMed]
- Steinkohl F, Pichler R, Junker D. Short review of biparametric prostate MRI. Memo. 2018;11(4):309-312. [CrossRef] [PubMed]
- Tamada, T.; Kido, A.; Yamamoto, A.; Takeuchi, M.; Miyaji, Y.; Moriya, T.; Sone, T. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection with PI-RADS Version 2.1. J. Magn. Reason. Imaging 2021, 53, 283–291. [Google Scholar] [CrossRef] [PubMed]
- Twilt JJ, van Leeuwen KG, Huisman HJ, Fütterer JJ, de Rooij M. Artificial intelligence based algorithms for prostate cancer classification and detection on magnetic resonance imaging: a narrative review. Diagnostics. 2021 May 26;11(6):959.
- Baltzer PAT, Clauser P. Applications of artificial intelligence in prostate cancer imaging. Curr Opin Urol. 2021 Jul 1;31(4):416-423. [CrossRef] [PubMed]
- Zhao LT, Liu ZY, Xie WF, Shao LZ, Lu J, Tian J, Liu JG. What benefit can be obtained from magnetic resonance imaging diagnosis with artificial intelligence in prostate cancer compared with clinical assessments? Mil Med Res. 2023 Jun 26;10(1):29. [CrossRef] [PubMed]
- Zhu L, Pan J, Mou W, Deng L, Zhu Y, Wang Y, Pareek G, Hyams E, Carneiro BA, Hadfield MJ, El-Deiry WS, Yang T, Tan T, Tong T, Ta N, Zhu Y, Gao Y, Lai Y, Cheng L, Chen R, Xue W. Harnessing artificial intelligence for prostate cancer management. Cell Rep Med. 2024 Apr 16;5(4):101506. [CrossRef] [PubMed]
- Saha, A.; Twilt, J.J.; Bosma, J.S.; Van Ginneken, B.; Yakar, D.; Elschot, M.; Veltman, J.; Fütterer, J.; de Rooij, M.; Huisman, H. Artificial Intelligence and Radiologists at Prostate Cancer Detection in MRI: The PI-CAI Challenge (Study Protocol). Available online: https://zenodo.org/record/6624726#.ZGvT2nbMKM9 (accessed on 28 April 2023).
- Saha, A et al. Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study The Lancet Oncology, 2024 Volume 25, Issue 7, 879 – 887.
- Saha, A et al. Appendix Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study The Lancet Oncology, 2024 Volume 25, Issue 7.
- Yuan Y, Ahn E, Feng, D, Khadra M, Kim J.. Z-SSMNet: A Zonal-aware Self-Supervised Mesh Network for Prostate Cancer Detection and Diagnosis in bpMRI. 10.48550/arXiv.2022 2212.05808.
- Mayer, R.; Simone CB 2nd Skinner, W.; Turkbey, B.; Choyke, P. Pilot study for supervised target detection applied to spatially registered multiparametric MRI in order to non-invasively score prostate cancer. Comput. Biol. Med. 2018, 94, 65–73. [Google Scholar] [CrossRef] [PubMed]
- Mayer, R.; Simone, C.B., 2nd; Turkbey, B.; Choyke, P. Development and testing quantitative metrics from multi-parametric magnetic resonance imaging that predict Gleason score for prostate tumors. Quant. Imaging Med. Surg. 2022, 12, 1859–1870. [Google Scholar] [CrossRef] [PubMed]
- Mayer, R.; Turkbey, B.; Choyke, P.; Simone, C.B., 2nd. Combining and Analyzing Novel Multi-parametric MRI Metrics for Predicting Gleason Score. Quant. Imaging Med. Surg. 2022, 12, 3844–3859. [Google Scholar] [CrossRef] [PubMed]
- Mayer, R.; Turkbey, B.; Choyke, P.; Simone, C.B., 2nd. Pilot Study for Generating and Assessing Nomograms and Decision Curves Analysis to Predict Clinically Significant Prostate Cancer Using Only Spatially Registered Multi-Parametric MRI. Front. Oncol. Sec. Genitourin. Oncol. 2023, 13, 1066498. [Google Scholar] [CrossRef]
- Mayer R, Turkbey B, Choyke PL, Simone CB II. Application of Spectral Algorithm Applied to Spatially Registered Bi-Parametric MRI to Predict Prostate Tumor Aggressiveness: A Pilot Study. Diagnostics, 2023 13, 2008. [CrossRef]
- Mayer R, Turkbey B, Choyke PL, Simone CB, II. Relationship between Eccentricity and Volume Determined by Spectral Algorithms Applied to Spatially Registered Bi-Parametric MRI and Prostate Tumor Aggressiveness: A Pilot Study. Diagnostics 2023 13, 3238. [CrossRef]
- Egevad, L.; Delahunt, B.; Srigley, J.R.; Samaratunga, H. International Society of Urological Pathology (ISUP) grading of prostate cancer—An ISUP consensus on contemporary grading. APMIS 2016, 124, 433–435. [Google Scholar] [CrossRef] [PubMed]
- Ahdoot, M.; Wilbur, A.R.; Reese, S.E.; Lebastchi, A.H.; Mehralivand, S.; Gomella, P.T.; Bloom, J.; Gurram, S.; Siddiqui, M.; Pinsky, P.; et al. MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis. N. Engl. J. Med. 2020, 382, 917–928. [Google Scholar] [CrossRef] [PubMed]
- Strang, G. Linear Algebra and Its Applications, 4th ed.; Thomson, Brooks/Cole: Belmont, CA, USA, 2006.
- Chen, G.; Qian, S. Denoising of Hyperspectral Imagery Using Principal Component Analysis and Wavelet Shrinkage. IEEE Trans. Geosci. Remote Sens. 2011, 49, 973–80. [Google Scholar] [CrossRef]
- Friedman, J.H. Regularized Discriminant Analysis. J. Am. Stat. Assoc. 1989, 84, 165–7. [Google Scholar] [CrossRef]
- Hosmer, D.W., Jr.; Lemeshow, S.; Sturdivant, R.X. Applied Logistic Regression, 2nd ed.; Wiley: Hoboken, NJ, USA, 2000; ISBN 978-0-471-35632-5. [Google Scholar]
- Fawcett, T. An Introduction to ROC Analysis. Pattern Recognit. Lett. 2006, 27, 861–874. [Google Scholar] [CrossRef]
- Manolakis D, Shaw G, Detection algorithms for hyperspectral imaging applications, IEEE Sign. Processing Magazine. 2002; 19: 29-43.
- Isensee F, Jaeger PF, Kohl SAA et al., “nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation,” Nature Methods, 2021 vol. 18, no. 2, 203-+.
- . Dong, Y. He, X. Qi et al., “MNet: Rethinking 2D/3D Networks for Anisotropic Medical Image Segmentation,” 2022. arXiv:2205.04846, 2022.
- Mardia KV, Kent JT, Bibby JM. Multivariate Analysis. Academic Press, 1979.
- Chatterjee S, Simonoff J. Handbook of Regression Analysis. Hoboken: John Wiley & Sons, 2013.
- Bae MS, Seo M, Kwang, Kim KG, Park IA, Moon WK. Quantitative MRI morphology of invasive breast cancer: correlation with immunohistochemical biomarkers and subtypes. Acta Radiol. 2015 Mar;56(3):269-75. [CrossRef]
- Yoon HJ, Park H, Lee HY, Sohn I, Ahn J and Lee SH. Prediction of tumor doubling time of lung adenocarcinoma using radiomic margin characteristics. Thoracic Cancer 2020; 11: 2600–2609.
- Baba T, Uramoto H, Takenaka M, et al..The tumour shape of lung adenocarcinoma is related to the postoperative prognosis. Interactive CardioVascular and Thoracic Surgery. 2012; 15: 73–76.





| R | p-value | AUROC [2.5%-97.5% CI] | |
|---|---|---|---|
| Independent Variable | |||
| Probability of CsPCa | 0.298 | 0.0554 | 0.503 [0.083-1.0] |
| ISUP (Linear Conversion) | 0.301 | 0.0525 | 0.503 [0.083-1.0] |
| Average Blob Volume | 0.512 | 0.00053 | 0.367 [0.0-0.909] |
| Total Volume | 0.355 | 0.021 | 0.501 [0.0-1.0] |
|
Independent Variable 1 (AI mostly) |
R1 (Uni-variate) |
Independent Variable 2 (Spectral/Statistical only) |
R2 (Uni-variate) |
Variable 1-Variable 2 Cross-Correlation |
R12 (Multi-variate) |
Probability (F-Statistic) |
|---|---|---|---|---|---|---|
| z-score | 0.532 | SCR (Modified Reg) | 0.57 | 0.985 | 0.595 | 0.0002 |
| Ave Blob Volume (AI) | 0.512 | SCR (2 PC removed) | 0.554 | 0.412 | 0.635 | 0.000042 |
| Ave Blob Volume (AI) | 0.512 | z-score | 0.532 | 0.167 | 0.683 | 0.0000059 |
| Ave Blob Volume (AI) | 0.512 | SCR (Reg) | 0.588 | 0.384 | 0.665 | 0.000012 |
| Ave Blob Volume (AI) | 0.512 | SCR (Modified Reg) | 0.57 | 0.219 | 0.695 | 0.0000026 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).